The authors thank Paula Agger, Rafael Saenz, and Elizabeth Krupinski for sharing their time and expertise on the process of FDA advisory committee meetings, and of other committee meetings more generally. The authors also thank participants at the 2023 Product and Service Innovation Conference, as well as seminar participants at the University of Cambridge Judge Business School, University College London School of Management, Goethe University Frankfurt, Massachusetts Institute of Technology Sloan School of Management, Nova School of Business and Economics, the Ohio State University’s Fisher College of Business, the University of Toronto Rotman School of Management, and the George Washington School of Business. Finally, the authors thank Kaitlyn Rodriguez, Irvy Yu, and Jon Ashley for their exceptional research assistance. A previous version of this paper was titled “How Voting Protocols Shape Committee Discussions and Outcomes: New Product Evaluations at the FDA.”
